Haystack Oncology

Curated by Signal

Developer of tumor-informed, personalized MRD testing technology for cancer treatment strategies

Overview

Developer of tumor-informed, personalized MRD testing technology for cancer treatment strategies. It is a tumor-informed, next-generation minimal residual disease test that detects ultralow levels of circulating tumor DNA to uncover residual disease after definitive surgery.

Key facts

Founded: 2022
Headquarters: Baltimore, United States
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

MEDENT
Software for practice management, EHR and patient communication
Health TechnologyAuburn, United States
KingSmith
Online store offering fitness euipments for home gym and offices
Health TechnologyUnited States
Gold River Productions
Provider of medical marijuana card on doctor consultation
Health TechnologyPalm Coast, United States

About Haystack Oncology

What does Haystack Oncology do?

Developer of tumor-informed, personalized MRD testing technology for cancer treatment strategies.

Where is Haystack Oncology headquartered?

Haystack Oncology is headquartered in Baltimore, United States.

When was Haystack Oncology founded?

Haystack Oncology was founded in 2022.

Which sector is Haystack Oncology in?

Haystack Oncology operates in Health Technology.

Who are Haystack Oncology's competitors?

Companies similar to Haystack Oncology include MEDENT, KingSmith, and Gold River Productions.